Clinical Trial Update: Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bendamustine/rituximab induction followed by maintenance rituximab and lenalidomide in previously untreated CLL/SLL; study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Lenalidomide (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Lymphoid Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2023-06-27